SCHEMBL3352865

SCHEMBL3352865

CN1CCC(n2ccc3ccc(N)cc32)CC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 2/20 0.51
HTR1B P28222 2/20 0.51
HTR1A P08908 1/20 0.51
HTR1F P30939 1/20 0.51
NOS3 P29474 6/20 0.48
NOS1 P29475 6/20 0.48
NOS2 P35228 4/20 0.47
DRD2 P14416 1/20 0.46
SLC6A4 P31645 1/20 0.46
SCD O00767 7/20 0.42
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
PRKCI P41743 1/20 0.40
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12253683 0.94 NOS3 (0.55) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL2266494 0.88 PRKCI (0.51) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL30594683 0.88 PRKCI (0.51) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL3358885 0.85 DRD2 (0.67) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL3357163 0.84 OPRM1 (0.43) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL3355691 0.84 DRD2 (0.52) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL12367572 0.83 NOS3 (0.54) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL3355266 0.83 NOS3 (0.45) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL3355563 0.82 OPRM1 (0.47) HTR1DHTR1BHTR1AHTR1FNOS3
SCHEMBL6742084 0.82 HTR1A (0.51) HTR1DHTR1BHTR1AHTR1FNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed
CN-1510034-A Indazole compound, preparing method thereof and medicine composition containing the same ɪά��ʵ���� 2004-07-07 CN disclosed
EP-0902027-B1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them ADIR (FR) 2001-07-25 EP disclosed
US-6046205-A FOR TREATMENT OF VENOUS INSUFFICIENCY AND OF ASSOCIATED DISORDERS, AND ALSO IN THE TREATMENT OF MIGRAINE ADIR ET COMPAGNIE (FR) 2000-04-04 US disclosed
US-6020336-A Indole and indazole compounds LES LABORATOIRES SERVIER (FR) 2000-02-01 US disclosed
EP-0902027-A1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1999-03-17 EP disclosed